本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Artiva Biotherapeutics, Inc.

11.52
+0.59005.40%
盤後11.680.1600+1.39%19:51 EDT
成交量:30.72萬
成交額:347.10萬
市值:5.63億
市盈率:-3.59
高:11.70
開:10.83
低:10.49
收:10.93
52周最高:14.53
52周最低:2.22
股本:4,888.58萬
流通股本:1,989.95萬
量比:1.01
換手率:1.54%
股息:- -
股息率:- -
每股收益(TTM):-3.2084
每股收益(LYR):-3.4309
淨資產收益率:-36.58%
總資產收益率:-22.34%
市淨率:1.62
市盈率(LYR):-3.36

資料載入中...

2026/08/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/10

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/22

重要事件披露

Form 8-K - Current report
2026/05/19

重要事件披露

Form 8-K - Current report
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/18

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/08

重要事件披露

Form 8-K - Current report
2026/05/08

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/08

重要事件披露

Form 8-K - Current report
2026/04/30

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2026/03/10

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/10

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans